Trendelenburg-like gait, instability and altered step patterns in a mouse model for limb girdle muscular dystrophy 2i

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Maricelli, Joseph W ^a   Lu, Qi L ^b   Lin, David C ^c   Rodgers, Buel D ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

^c Washington State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUKUTIN RELATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY SURFACE; C57BL 6 MOUSE; CONTROLLED STUDY; FEMALE; FORCE INTENSITY; GAIT INSTABILITY; LIMB GIRDLE MUSCULAR DYSTROPHY; LIMB GIRDLE MUSCULAR DYSTROPHY 2I; MALE; MOTION ANALYSIS SYSTEM; MOUSE; MOUSE MODEL; MOUSE MUTANT; MOUSE STRAIN; NEUROLOGIC GAIT DISORDER; NONHUMAN; P448L MOUSE; PARAMETERS; PAW CONTACT; QUANTITATIVE ANALYSIS; STANCE SUPPORT; STANDING; STRIDE LENGTH; SWING TIME; TRENDELENBURG GAIT; WALKING SPEED; WILD TYPE MOUSE; ANIMAL; C57BL MOUSE; DISEASE MODEL; GAIT; MOVEMENT (PHYSIOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; WALKING;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GAIT; MALE; MICE; MICE, INBRED C57BL; MOVEMENT; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; WALKING;

EID: 84991106978     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0161984     Document Type: Article

References (51)

1. Mercuri E, LongmanC. Congenital muscular dystrophy. Pediatric annals. 2005; 34(7):560-2, 4-8. Epub 2005/08/12. PMID: 16092630.
2. Rosales XQ, al-Dahhak R, Tsao CY. Childhood onset of limb-girdlemuscular dystrophy. Pediatric neurology. 2012; 46(1):13-23. Epub 2011/12/27. doi: 10.1016/j.pediatrneurol.2011.08.014 PMID: 22196486.
3. Nigro V, Savarese M. Genetic basis of limb-girdlemuscular dystrophies: the 2014 update. Actamyologica: myopathies and cardiomyopathies: official journal of the Mediterranean Society of Myology/edited by the Gaetano Conte Academy for the study of striatedmuscle diseases. 2014; 33(1):1-12. Epub 2014/05/21. PMID: 24843229; PubMed Central PMCID: PMCPmc4021627.
4. Awano H, Blaeser A,Wu B, Lu P, Keramaris-Vrantsis E, Lu Q. Dystroglycanopathy muscles lacking functional glycosylation of alpha-dystroglycan retain regeneration capacity. Neuromuscular disorders: NMD. 2015; 25(6):474-84. Epub 2015/05/06. doi: 10.1016/j.nmd.2015.03.004 PMID: 25937147.
5. Ghaoui R, Cooper ST, Lek M, Jones K, Corbett A, Reddel SW, Needham M, Liang C,Waddell LB, Nicholson G, O'Grady G, Kaur S, Ong R, Davis M, Sue CM, Laing NG, North KN, MacArthur DG, Clarke NF. Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy: Outcomes and Lessons Learned. JAMA neurology. 2015:1-9. Epub 2015/10/06. doi: 10.1001/jamaneurol.2015.2274 PMID: 26436962.
6. Godfrey C, Foley AR, Clement E, Muntoni F. Dystroglycanopathies: coming into focus. Curr Opin Genet Dev. 2011; 21(3):278-85. Epub 2011/03/15. doi: 10.1016/j.gde.2011.02.001 PMID: 21397493.
7. Chan YM, Keramaris-Vrantsis E, Lidov HG, Norton JH, Zinchenko N, Gruber HE, Thresher R, Blake DJ, Ashar J, Rosenfeld J, Lu QL. Fukutin-related protein is essential for mousemuscle, brain and eye development andmutation recapitulates the wide clinical spectrumsof dystroglycanopathies. Hum Mol Genet. 2010; 19(20):3995-4006. Epub 2010/08/03. doi: 10.1093/hmg/ddq314 PMID: 20675713.
8. Blaeser A, Keramaris E, Chan YM, Sparks S, Cowley D, Xiao X, Lu QL. Mouse models of fukutinrelated proteinmutations show a wide range of disease phenotypes. Human genetics. 2013; 132 (8):923-34.Epub 2013/04/18. doi: 10.1007/s00439-013-1302-7 PMID: 23591631.
9. Stedman HH, Sweeney HL, Shrager JB, MaguireHC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM. The mdx mouse diaphragm reproduces the degenerative changes of Duchennemuscular dystrophy. Nature. 1991; 352(6335):536-9. doi: 10.1038/352536a0 PMID: 1865908.
10. Quinlan JG, Hahn HS,Wong BL, Lorenz JN,Wenisch AS, Levin LS. Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscular disorders:NMD. 2004; 14(8-9):491-6. Epub 2004/09/01. doi: 10.1016/j.nmd.2004.04.007 PMID: 15336690.
11. Petri H, Sveen M-L, Thune JJ, Vissing C, Dahlqvist JR, Witting N, Bundgaard H, Køber L, Vissing J. Progression of cardiac involvement in patients with limb-girdle type 2 and Becker muscular dystrophies: A 9-year follow-up study. International Journal of Cardiology. 2015; 182(0):403-11. http://dx.doi.org/10. 1016/j.ijcard.2014.12.090.
12. Margeta M, Connolly AM, Winder TL, Pestronk A, Moore SA. Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I. Muscle Nerve. 2009; 40(5):883-9. doi: 10.1002/mus.21432 PMID: 19705481; PubMed Central PMCID: PMC2862182.
13. Hickey M, Kosmalska A, Enayati J, Cohen R, Zeitlin S, Levine M, Chesselet M. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience. 2008; 157:280-95. doi: 10.1016/j.neuroscience.2008.08.041 PMID: 18805465
14. Mercuri E, Brockington M, Straub V, Quijano-Roy S, Yuva Y, HerrmannR, Brown SC, Torelli S, Dubowitz V, Blake DJ, RomeroNB, EstournetB, Sewry CA, Guicheney P, Voit T, Muntoni F. Phenotypic spectrumassociated withmutations in the fukutin-related protein gene. Ann Neurol. 2003; 53(4):537-42. Epub 2003/04/01. doi: 10.1002/ana.10559 PMID: 12666124.
15. Krag TO, Vissing J. A New Mouse Model of Limb-Girdle Muscular Dystrophy Type 2I Homozygous for the CommonL276I Mutation Mimicking the Mild Phenotype in Humans. Journal of neuropathology and experimental neurology. 2015; 74(12):1137-46. Epub 2015/11/18. doi: 10.1097/nen. 0000000000000260 PMID: 26574668.
16. Xu L, Lu PJ, Wang CH, Keramaris E, Qiao C, Xiao B, Blake DJ, Xiao X, Lu QL. Adeno-Associated virus 9 mediated FKRP gene therapy restores functional glycosylation of alpha-dystroglycan and improves muscle functions. Mol Ther. 2013; 21(10):1832-40. doi: 10.1038/mt.2013.156 PMID: 23817215; PubMed Central PMCID: PMC3808132.
17. Goddard MA, Mack DL, Czerniecki SM, Kelly VE, Snyder JM, Grange RW, LawlorMW, Smith BK, Beggs AH, Childers MK. Muscle pathology, limb strength,walking gait, respiratory function and neurological impairment establish disease progression in the p.N155K canine model of X-linkedmyotubular myopathy. Annals of translational medicine. 2015; 3(18):262. Epub 2015/11/26. doi: 10.3978/j.issn. 2305-5839.2015.10.31 PMID: 26605308; PubMed Central PMCID: PMCPmc4630545.
18. Ropars J, Lemeur M, Vuillerot C, Tiffreau V, Peudenier S, Cuisset JM, Pereon Y, Leboeuf F, Delporte L, Delpierre Y, Gross R, Brochard S. Changes inmuscle activation during gait of children with duchennemuscular dystrophy. Computer methods in biomechanics and biomedical engineering. 2015; 18 Suppl 1:2042-3. Epub 2015/10/16. doi: 10.1080/10255842.2015.1069615 PMID: 26467719.
19. Rijken NH, van Engelen BG, GeurtsAC, Weerdesteyn V. Dynamic stability during level walking and obstacle crossing in persons with facioscapulohumeral muscular dystrophy. Gait & posture. 2015; 42 (3):295-300. Epub 2015/07/02. doi: 10.1016/j.gaitpost.2015.06.005 PMID: 26130572.
20. Simões GF, Benitez SU, Oliveira ALR. Granulocyte colony-stimulating factor (G-CSF) positive effects on muscle fiber degeneration and gait recovery after nerve lesion in MDX mice. Brain and Behavior. 2014; 4(5):738-53. doi: 10.1002/brb3.250 PMID: 25328849
21. Moreno Izco F, Mendioroz IriarteM, Poza Aldea JJ, MartiMasso JF, Lopez de Munain A. [Analysis of gait and movement of upper limbs in muscular dystrophies]. Neurologia (Barcelona, Spain). 2005; 20 (7):341-8. Epub 2005/09/16. PMID: 16163577.
22. Pane M, Mazzone ES, Sivo S, Fanelli L, De Sanctis R, D'Amico A, Messina S, Battini R, Bianco F, Scutifero M, Petillo R, Frosini S, Scalise R, Vita GL, BrunoC, Pedemonte M, Mongini T, Pegoraro E, Brustia F, Gardani A, Berardinelli A, Lanzillotta V, Viggiano E, Cavallaro F, Sframeli M, Bello L, Barp A, Busato F, Bonfiglio S, Rolle E, Colia G, Bonetti A, Palermo C, Graziano A, D'Angelo G, Pini A, Corlatti A, Gorni K, Baranello G, Antonaci L, Bertini E, Politano L, Mercuri E. The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys. PLoS currents. 2014; 6. Epub 2015/02/03. doi: 10.1371/currents.md.a93d9904d57dcb08936f2ea89bca6fe6 PMID: 25642376; PubMed Central PMCID: PMCPmc4208936.
23. McDonald CM, Henricson EK, Han JJ, Abresch RT, Nicorici A, Elfring GL, Atkinson L, Reha A, Hirawat S, Miller LL. The 6-minutewalk test as a new outcome measure in Duchenne muscular dystrophy. Muscle & nerve. 2010; 41(4):500-10. Epub 2009/11/27. doi: 10.1002/mus.21544 PMID: 19941337.
24. Pegoraro E, Hoffman EP. Limb-Girdle Muscular Dystrophy Overview. In: Pagon RA, Adam MP, Ardinger HH,Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews(R). Seattle (WA): University ofWashington, Seattle. All rights reserved.; 1993.
25. Papa R, Madia F, Bartolomeo D, Trucco F, Pedemonte M, Traverso M, Broda P, BrunoC, Zara F, Minetti C, FiorilloC. Genetic and Early Clinical Manifestations of Females Heterozygous for Duchenne/Becker Muscular Dystrophy. Pediatric neurology. 2015. Epub 2016/01/01. doi: 10.1016/j.pediatrneurol. 2015.11.004 PMID: 26718981.
26. Hensinger RN. Limp. Pediatric clinics of NorthAmerica. 1986; 33(6):1355-64. Epub 1986/12/01. PMID: 3786002.
27. Pai VS. Significance of the Trendelenburg test in total hip arthroplasty. Influence of lateral approaches. The Journal of arthroplasty. 1996; 11(2):174-9. Epub 1996/02/01. PMID: 8648312.
28. Möller KA, Berge O-G, Hamers FPT. Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: Effects of morphine and rofecoxib. Journal of Neuroscience Methods. 2008; 174(1):1-9. doi: 10.1016/j.jneumeth.2008.06. 017 PMID: 18634823
29. Mendes C, Bartos I, Marka Z, Akay T, Marka S, Mann R. Quantification of gait parameters in freely walking rodents. BMC Biology. 2015; 13(1):50. doi: 10.1186/s12915-015-0154-0
30. BellarditaC, KiehnO. Phenotypic Characterization of Speed-Associated Gait Changes in Mice Reveals Modular Organization of Locomotor Networks. Current biology: CB. 2015; 25(11):1426-36. doi: 10. 1016/j.cub.2015.04.005 PMID: PMC4469368.
31. Smith BJH, Cullingford L, Usherwood JR. Identification of mouse gaits using a novel force-sensing exercise wheel. Journal of Applied Physiology. 2015; 119(6):704-18. doi: 10.1152/japplphysiol.01014. 2014 PMID: 26139220
32. Albuquerque MA, Abath Neto O, Silva FM, Zanoteli E, Reed UC. Limb-girdlemuscular dystrophy type 2A in Brazilian children. Arquivos de neuro-psiquiatria. 2015; 73(12):993-7. Epub 2015/12/18. doi: 10. 1590/0004-282x20150168 PMID: 26677118.
33. Alexander R.Walking, running and jumping. Locomotion of animals. 1982:81-113. doi: 10.1007/978-94-011-6009-4-5
34. Hammarén E, Kjellby-Wendt G, LindbergC. Muscle force, balance and falls inmuscular impaired individuals withmyotonic dystrophy type 1: A five-year prospective cohort study. Neuromuscular Disorders. 2015; 25(2):141-8. doi: 10.1016/j.nmd.2014.11.004 PMID: 25475393
35. McDonald CM, Henricson EK, Abresch RT, Florence JM, Eagle M, Gappmaier E, Glanzman AM, Spiegel R, Barth J, Elfring G, Reha A, Peltz S. The 6-minutewalk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. Muscle & nerve. 2013; 48(3):343-56. Epub 2013/05/18. doi: 10.1002/mus.23902 PMID: 23681930; PubMed Central PMCID: PMCPmc3824082.
36. Alexander RM. Bipedal animals, and their differences from humans. Journal of Anatomy. 2004; 204 (5):321-30. doi: 10.1111/j.0021-8782.2004.00289.x PMID: PMC1571302.
37. Flynn JM, Widmann RF. The limping child: evaluation and diagnosis. The Journal of the American Academy of Orthopaedic Surgeons. 2001; 9(2):89-98.Epub 2001/04/03. PMID: 11281633.
38. FischerD, Walter MC, Kesper K, Petersen JA, Aurino S, Nigro V, Kubisch C, Meindl T, Lochmuller H, Wilhelm K, Urbach H, Schroder R. Diagnostic value ofmuscle MRI in differentiating LGMD2I from other LGMDs. Journal of neurology. 2005; 252(5):538-47. doi: 10.1007/s00415-005-0684-4 PMID: 15726252.
39. Vasudevan PN, Vaidyalingam KV, Nair PB. Can Trendelenburg's sign be positive if the hip is normal? The Journal of bone and joint surgery British volume. 1997; 79(3):462-6.Epub 1997/05/01. PMID: 9180330.
40. Read L, Galasko CS. Delay in diagnosing Duchenne muscular dystrophy in orthopaedic clinics. The Journal of bone and joint surgery British volume. 1986; 68(3):481-2. Epub 1986/05/01. PMID: 3733820.
41. de los Angeles Avaria M, Kleinsteuber K, Herrera L, Carvallo P. [Delayed diagnosis of Duchennemuscular dystrophy in Chile]. Revista medica de Chile. 1999; 127(1):65-70. Epub 1999/08/07. PMID: 10436681.
42. Papa R, Madia F, Bartolomeo D, Trucco F, Pedemonte M, Traverso M, Broda P, BrunoC, Zara F, Minetti C, FiorilloC. Genetic and Early Clinical Manifestations of Females Heterozygous for Duchenne/Becker Muscular Dystrophy. Pediatric neurology. http://dx.doi.org/10.1016/j.pediatrneurol.2015.11. 004.
43. Makino Y, Tsujiuchi N, Ito A, Koizumi T, Nakamura S, Matsuda Y, Tsuchiya Y, Hayashi Y. Quantitative evaluation of unrestrained human gait on change in walking velocity. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual Conference. 2014;2014:2521-4. Epub 2015/01/09. doi: 10.1109/embc.2014.6944135 25570503.
44. AdachiW, Tsujiuchi N, Koizumi T, Aikawa M, Shiojima K, Tsuchiya Y, Inoue Y. Development of walking analysis system consisting of mobile force plate and motion sensor. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual Conference. 2011;2011:4022-5. Epub 2012/01/19. doi: 10.1109/iembs.2011.6090999 22255222.
45. Webb AA, Kerr B, Neville T, Ngan S, Assem H. Kinematics and Ground Reaction Force Determination: A Demonstration Quantifying Locomotor Abilities of Young Adult, Middle-Aged, and GeriatricRats. 2011;(48: ):e2138. doi: 10.3791/2138
46. Shklyar I, Pasternak A, Kapur K, Darras BT, Rutkove SB. Composite biomarkers for assessing Duchennemuscular dystrophy: an initial assessment. Pediatric neurology. 2015; 52(2):202-5. Epub 2014/12/03. doi: 10.1016/j.pediatrneurol.2014.09.014 PMID: 25447928; PubMed Central PMCID: PMCPmc4336219.
47. Mendell JR, Rodino-Klapac LR, Rosales-Quintero X, Kota J, Coley BD, Galloway G, Craenen JM, Lewis S, Malik V, Shilling C, Byrne BJ, Conlon T, Campbell KJ, Bremer WG, Viollet L,Walker CM, Sahenk Z, Clark KR. Limb-girdlemuscular dystrophy type 2D gene therapy restores alpha-sarcoglycan and associated proteins. Annals of neurology. 2009; 66(3):290-7. Epub 2009/10/03. doi: 10.1002/ana. 21732 PMID: 19798725.
48. Mendell JR, Rodino-Klapac L, Sahenk Z, Malik V, Kaspar BK,Walker CM, Clark KR. Gene therapy for muscular dystrophy: lessons learned and path forward. Neurosci Lett. 2012; 527(2):90-9. doi: 10.1016/j.neulet.2012.04.078 PMID: 22609847; PubMed Central PMCID: PMC3492936.
49. Odom GL, Gregorevic P, Allen JM, Chamberlain JS. Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6. Molecular therapy: the journal of the American Society of Gene Therapy. 2011; 19(1):36-45.Epub 2010/09/23. doi: 10.1038/mt.2010.205 PMID: 20859263; PubMed Central PMCID: PMCPmc3017440.
50. ZincarelliC, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther. 2008; 16(6):1073-80. mt200876 [pii] doi: 10.1038/mt.2008.76 PMID: 18414476.
51. Wang B, Li J, Xiao X. Adeno-Associated virus vector carryinghuman minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci U S A. 2000; 97(25):13714-9. PMID: 11095710.